Round 3

Survey instruments

Will be shared soon

SUMMARY OF THE GPC ROUND 3 (JAN 1991-NOV 1992): Demographic and Health/Medical Surveillance

Round (Period)	Items	Notes
JAN 1991-NOV 1992	Protocol Title	Epidemiology and genetics of communicable and non-communicable diseases in the General Population Cohort in Kyamulibwa, Uganda
	Objectives in summary	To determine the prevalence of HIV among GPC residents stratified by age and sex, comparing children (< years) and adolescents /adults (&ge 13 years). To assess the burden of self-reported sexually transmitted infection (STI) symptoms—including genital ulcers and vaginal discharge—among adolescents and adults (&ge 13 years) in the GPC cohort.

Summary of the house-to-house Census

Characteristic	Population(Male + Female)	Females	Males
Start and end date	Jan 1991-Nov 1992
#Households at end of round	249
#Residents by the end of the round	10,578	5,309 (50.2%)	5,269 (49.8%)
#Residents during the round	9,936	5,005 (50.4%)	4,931 (49.6%)

#New births
#In-migrants
#Out-migrants
#Deaths	165	85 (51.5%)	80 (48.5%)

Age range (in years)	0-97	0-96	0-97

Figure 1: Overall population pyramid (age-sex distribution, counts and percent)

Summary of the adult medical survey

Characteristic	Population(Male + Female)	Females	Males
Start and end date	02 Jan 2007 to 25 Oct 2008
Eligibility criteria	GPC Residents	≥13 years	≥13 years
#Eligible for medical survey*
#Households (participation % – % of all HHs with eligible participants that attended medical survey)	611
#participants (participation % – % of all eligible participants)	6,223	3,578 (57.5%)	2,645 (42.5%)

Age range (in years)	13 – 98	13 – 91	13 – 98

HIV prevalence (95% CI) n=4,789	160 (3.3%)	113 (4.1%)	47 (2.3%)

Summary of the child medical survey

Characteristic	Population(Male + Female)	Females	Males
Start and end date
Eligibility criteria <13 years old
#Households (HHs) with eligible participants that attended medical survey	520
# of participants that attended the medical survey	5,660	2,805 (49.6%)	2,855 (50.4%)

Age range (in years)	0 – 12	0 – 12	0 – 12

HIV prevalence (95% CI)	24 (0.5%)	11(0.5%)	13 (0.5 %)